About FemTherapeutics
FemTherapeutics is a Healthcare company based in Montreal (Canada) founded in 2019 by Inara Lalani and Negin Ashouri. Provider of personalized medicine for pelvic health of the women. FemTherapeutics has raised $1.8 million across 1 funding round from investors including 2048 Ventures, Invest Quebec and The51. Its chief executive, as recorded, is Lydia Aguirre Perales. FemTherapeutics offers products and services including Customizable Pessary and Clinician Platform. Its focus areas include Life Sciences, Women Health, Medical Devices and Therapy. Its legal entity is FemTherapeutics Inc.
Company details
FemTherapeutics provider of personalized medicine for pelvic health of the women. The company offers its flagship product Pelvic Organ Prolapse (POP) for women by creating customized vaginal pessaries that are customized to treat pelvic floor issues in different women. The company claims to be in the clinical stage for its products.
- Headquarters Montreal, Canada
- Founders Inara Lalani, Negin Ashouri
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website femtherapeutics.com
- Social LinkedIn Facebook Instagram
- Legal Name Femtherapeutics Inc.
- Total Equity Funding$1.8M (USD)
in 1 rounds
- Latest Funding Round$1.8M (USD), Seed
Jun 2023
- Investors2048 Ventures
& 3 more
Products & Services of FemTherapeutics
FemTherapeutics offers a comprehensive portfolio of products and services, including Customizable Pessary and Clinician Platform.
Personalized device for treating pelvic floor disorders using AI and 3D printing.
Platform to aid decision-making and workflow for gynecological treatments.
Funding Insights of FemTherapeutics
FemTherapeutics has successfully raised a total of $1.8M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.8 million completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.8M
- Total Rounds 1
- Last Round Seed — $1.8M
- First Round $1.8M
(Jun 2023)
- Investors Count 4
All 1 funding rounds of FemTherapeutics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2023 | $1.8M | Seed | – | 2048 Ventures |
4 investors in total: 4 institutional.
Investors in FemTherapeutics
FemTherapeutics has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include 2048 Ventures, Invest Quebec and The51.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage venture capital investments are provided by 2048 Ventures. | 2048.vc | New York, United States | ||
The51 is focused on funding women-led and gender-diverse businesses. | the51.com | Calgary, Canada | ||
SheBoot is focused on supporting women tech entrepreneurs. | sheboot.ca | Ottawa, Canada | ||
Business guidance for corporate companies and startups | investquebec.com | Quebec City, Canada |
Investor details for FemTherapeutics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of FemTherapeutics
3 people are tracked at FemTherapeutics (3 in leadership).
| Name | Role | Group |
|---|---|---|
Inara Lalani | Co-Founder | Leadership |
Negin Ashouri | Co-Founder | Leadership |
Lydia Aguirre Perales | CEO | Leadership |
Complete people profiles for FemTherapeutics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of FemTherapeutics
2 dated milestones of FemTherapeutics across 4 years, from founding to its latest funding, stage changes and deals.
- Founded FemTherapeutics is founded.
- Funding First funding round of $1.8M.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Femtherapeutics
Complete news archive for FemTherapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about FemTherapeutics
FemTherapeutics was founded in 2019 and raised its 1st funding round 4 years after it was founded.
FemTherapeutics is headquartered in Montreal, Canada. It is registered at Montreal, Quebec, Canada.
Lydia Aguirre Perales is the CEO of FemTherapeutics, as recorded in our data.
FemTherapeutics is a funded company, having raised a total of $1.8M across 1 funding round to date. The company's 1st funding round was a Seed of $1.8M, raised on Jun 2023.
FemTherapeutics provider of personalized medicine for pelvic health of the women. The company offers its flagship product Pelvic Organ Prolapse (POP) for women by creating customized vaginal pessaries that are customized to treat pelvic floor issues in different women. The company claims to be in the clinical stage for its products.
FemTherapeutics offers Customizable Pessary and Clinician Platform.
FemTherapeutics has 4 investors. Key investors include 2048 Ventures, Invest Quebec, The51, and SheBoot.
FemTherapeutics operates through Femtherapeutics Inc..